불러오는 중...
여기 실린 모든 기업을 성장성과 현금 창출력에 관한 동일한 다섯 가지 검사로 평가했습니다. 이는 오늘 보고된 대로의 산업을 설명할 뿐, 이 중 무엇을 사야 하는지를 말하지는 않습니다.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | US$138.7B | US$547.02 | 35.22 | US$13B | 30.7% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | US$101.3B | US$959.45 | 21.18 | US$16.9B | 28.5% |
| MRNA | Moderna, Inc. | C- | US$100.6B | US$248.70 | — | US$2.5B | -110.5% |
| ARGX | ARGENX SE | 등급 없음 | US$60.5B | US$977.29 | 49.94 | — | — |
| ONC | BEONE MEDICINES LTD. | A+ | US$48B | US$420.06 | 53.85 | US$6.6B | 13.9% |
| RPRX | Royalty Pharma plc | C+ | US$40.1B | US$69.97 | 45.73 | US$2.6B | 25.7% |
| RVMD | Revolution Medicines, Inc. | F | US$39.1B | US$180.66 | — | US$0.00 | — |
| ROIV | ROIVANT SCIENCES LTD. | B- | US$30.3B | US$41.85 | — | US$41.1M | -838.2% |
| INSM | INSMED INC | C- | US$26.5B | US$120.64 | — | US$1.5B | -39.9% |
| INCY | INCYTE CORPORATION | C | US$24.9B | US$122.23 | 65.01 | US$6B | 6.7% |
| BNTX | BioNTech SE | F | US$22B | US$87.64 | — | US$2.7B | -60.9% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | B+ | US$21.4B | US$159.80 | 68.58 | US$3.7B | 71.3% |
| NCNA | NUCANA PLC | 등급 없음 | US$19.5B | US$0.94 | — | — | — |
| EXEL | EXELIXIS, INC. | A+ | US$17.3B | US$70.71 | 21.17 | US$2.5B | 35.5% |
| ASND | Ascendis Pharma A/S | D | US$16.1B | US$259.10 | — | US$1.2B | -21.8% |
| JAZZ | Jazz Pharmaceuticals plc | A | US$15.9B | US$248.18 | 80.84 | US$4.7B | 4.4% |
| BBIO | BridgeBio Pharma, Inc. | B | US$15.5B | US$79.53 | — | US$945.5M | -60.7% |
| SMMT | Summit Therapeutics Inc. | 등급 없음 | US$13.3B | US$16.63 | — | — | — |
| AKTX | Akari Therapeutics Plc | 등급 없음 | US$11.9B | US$7.62 | — | — | — |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | US$11.6B | US$101.69 | 25.36 | US$1.8B | 26.9% |
| KYMR | KYMERA THERAPEUTICS, INC. | F- | US$11.5B | US$134.90 | — | US$102.2M | -341.8% |
| TECH | BIO-TECHNE Corp | A+ | US$11.4B | US$72.78 | 66.77 | US$1.2B | 14.0% |
| BMRN | BioMarin Pharmaceutical Inc | B | US$11.3B | US$58.32 | — | US$3.7B | -0.5% |
| PCVX | VAXCYTE, INC. | 등급 없음 | US$10.9B | US$68.62 | — | — | — |
| SYRE | SPYRE THERAPEUTICS, INC. | D | US$10.1B | US$106.77 | — | US$0.00 | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | B- | US$10.1B | US$432.64 | — | US$1.4B | -10.9% |
| TGTX | TG THERAPEUTICS, INC. | A+ | US$9.9B | US$65.75 | 98.13 | US$897.8M | 11.8% |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | US$9.7B | US$346.46 | — | US$0.00 | — |
| KRYS | Krystal Biotech, Inc. | A+ | US$9.2B | US$308.82 | 41.90 | US$470M | 47.9% |
| PTGX | PROTAGONIST THERAPEUTICS, INC. | A+ | US$8.8B | US$134.76 | 28.61 | US$551.7M | 62.0% |
| CORT | CORCEPT THERAPEUTICS INC | A+ | US$8.2B | US$74.52 | 58.68 | US$963.6M | 16.8% |
| CYTK | CYTOKINETICS, INCORPORATED | D | US$8.2B | US$58.52 | — | US$113.3M | -686.6% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | US$7.8B | US$149.20 | — | US$865.3M | -18.2% |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | US$7.8B | US$112.18 | — | US$280.7M | -69.0% |
| TWST | Twist Bioscience Corporation | C- | US$7.7B | US$122.71 | — | US$459.4M | -28.3% |
| IMVT | Immunovant, Inc. | 등급 없음 | US$7.7B | US$37.04 | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | 등급 없음 | US$7.3B | US$107.10 | — | — | — |
| ABVX | Abivax S.A. | 등급 없음 | US$7.2B | US$91.37 | — | — | — |
| IBRX | IMMUNITYBIO, INC. | C | US$7.1B | US$6.67 | — | US$182.6M | -607.8% |
| CAI | CARIS LIFE SCIENCES, INC. | A | US$7B | US$24.50 | 14.76 | US$1B | 9.2% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | F- | US$7B | US$49.36 | — | US$450.8M | -160.6% |
| KOD | Kodiak Sciences Inc. | 등급 없음 | US$6.9B | US$109.23 | — | — | — |
| MANE | Veradermics, Inc | 등급 없음 | US$6.6B | US$156.30 | — | — | — |
| CGON | CG Oncology, Inc. | F- | US$6.5B | US$72.66 | — | US$6.2M | -3,851.1% |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | C | US$6.3B | US$317.16 | 137.90 | US$253.8M | 20.3% |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | US$6.2B | US$94.64 | — | US$670.8M | -134.8% |
| BLTE | Belite Bio, Inc | 등급 없음 | US$6.1B | US$155.94 | — | — | — |
| ERAS | ERASCA, INC. | 등급 없음 | US$5.9B | US$16.80 | — | — | — |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F- | US$5.7B | US$46.54 | — | US$570K | -72,563.2% |
| PTCT | PTC Therapeutics, Inc. | D | US$5.4B | US$64.87 | — | US$1.2B | -9.2% |
| EWTX | Edgewise Therapeutics, Inc. | 등급 없음 | US$5.2B | US$47.58 | 5.82 | — | — |
| COGT | Cogent Biosciences, Inc. | 등급 없음 | US$5.1B | US$29.39 | — | — | — |
| DNTH | Dianthus Therapeutics, Inc. | F- | US$5B | US$89.24 | — | US$2M | -9,927.5% |
| TVTX | TRAVERE THERAPEUTICS, INC. | F- | US$5B | US$52.06 | — | US$651M | -18.7% |
| DFTX | Definium Therapeutics, Inc. | 등급 없음 | US$4.7B | US$34.46 | — | — | — |
| IONS | IONIS PHARMACEUTICALS, INC. | F- | US$4.7B | US$28.31 | — | US$960.1M | -56.9% |
| GPCR | Structure Therapeutics Inc. | 등급 없음 | US$4.5B | US$20.98 | — | — | — |
| CRSP | CRISPR THERAPEUTICS AG | F- | US$4.5B | US$45.89 | — | US$25.2M | -1,812.1% |
| TNGX | TANGO THERAPEUTICS, INC. | F | US$4.4B | US$25.71 | — | US$0.00 | — |
| RLAY | RELAY THERAPEUTICS, INC. | D- | US$4.4B | US$19.71 | — | US$10.4M | -2,837.0% |
| ZLAB | ZAI LAB LIMITED | F- | US$4.3B | US$26.43 | — | US$441.7M | -44.9% |
| XENE | Xenon Pharmaceuticals Inc. | F | US$4.1B | US$42.09 | — | US$0.00 | — |
| IRON | Disc Medicine, Inc. | 등급 없음 | US$4B | US$87.11 | — | — | — |
| ABCL | AbCellera Biologics Inc. | C- | US$3.9B | US$11.94 | — | US$67.9M | -218.5% |
| TARS | TARSUS PHARMACEUTICALS, INC. | B- | US$3.8B | US$76.71 | — | US$682.2M | -102.9% |
| ELVN | ENLIVEN THERAPEUTICS, INC. | 등급 없음 | US$3.8B | US$51.17 | — | — | — |
| DBVT | DBV TECHNOLOGIES S.A. | F- | US$3.7B | US$11.91 | — | US$3.8M | -5,405.3% |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | US$3.7B | US$8.08 | — | US$379M | -58.2% |
| PBLS | Parabilis Medicines, Inc. | 등급 없음 | US$3.7B | US$29.64 | — | — | — |
| VKTX | VIKING THERAPEUTICS, INC. | F | US$3.6B | US$28.43 | — | US$0.00 | — |
| LEGN | Legend Biotech Corp | C- | US$3.6B | US$19.54 | — | US$1.1B | -22.0% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | B | US$3.6B | US$28.36 | 135.05 | US$508.7M | 5.9% |
| VRDN | Viridian Therapeutics, Inc./DE | F- | US$3.5B | US$31.24 | — | US$26.3M | -1,724.1% |
| GMAB | Genmab A/S | B+ | US$3.4B | US$53.87 | 3.50 | US$3.9B | 21.0% |
| DYN | Dyne Therapeutics, Inc. | 등급 없음 | US$3.4B | US$17.98 | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D | US$3.3B | US$9.73 | — | US$890.8M | 3.8% |
| ACAD | ACADIA PHARMACEUTICALS INC. | B+ | US$3.2B | US$18.35 | 8.66 | US$1.2B | 30.1% |
| DNLI | Denali Therapeutics Inc. | F | US$3.2B | US$19.73 | — | US$0.00 | — |
| IDYA | IDEAYA Biosciences, Inc. | F- | US$3.2B | US$32.69 | — | US$36.5M | -1,149.6% |
| CELC | CELCUITY INC. | 등급 없음 | US$3.2B | US$64.31 | — | — | — |
| VCEL | VERICEL CORPORATION | A | US$3B | US$59.40 | 92.81 | US$324.2M | 10.3% |
| XNCR | Xencor, Inc | D- | US$3B | US$39.99 | — | US$200.5M | -58.8% |
| ADMA | ADMA BIOLOGICS, INC. | B+ | US$2.9B | US$13.19 | 17.13 | US$519.2M | 35.1% |
| MBX | MBX Biosciences, Inc. | 등급 없음 | US$2.9B | US$57.49 | — | — | — |
| RCUS | Arcus Biosciences, Inc. | F- | US$2.7B | US$18.80 | — | US$100M | -453.0% |
| BEAM | Beam Therapeutics Inc. | F- | US$2.7B | US$25.79 | — | US$146.6M | -73.9% |
| NAMS | NewAmsterdam Pharma Company N.V. | D- | US$2.5B | US$20.75 | — | US$25.9M | -789.9% |
| PVLA | Palvella Therapeutics, Inc. | 등급 없음 | US$2.4B | US$163.83 | — | — | — |
| CLDX | Celldex Therapeutics, Inc. | F- | US$2.4B | US$30.14 | — | US$158K | -195,608.9% |
| SEPN | Septerna, Inc. | F- | US$2.3B | US$48.54 | — | US$96.3M | -61.3% |
| BHVN | Biohaven Ltd. | 등급 없음 | US$2.3B | US$15.20 | — | — | — |
| IMNM | Immunome Inc. | F | US$2.3B | US$19.07 | — | US$0.00 | — |
| VIR | Vir Biotechnology, Inc. | C- | US$2.2B | US$13.12 | — | US$302.8M | -61.0% |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | US$2.2B | US$3.59 | — | US$68.2M | -697.1% |
| PHVS | Pharvaris N.V. | 등급 없음 | US$2.2B | US$34.12 | — | — | — |
| VERA | Vera Therapeutics, Inc. | 등급 없음 | US$2.2B | US$30.44 | — | — | — |
| LKFT | GALAPAGOS NV | D | US$2.2B | US$33.38 | 6.14 | US$1.2B | 28.9% |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | US$2.2B | US$16.21 | 7.08 | US$321.7M | 97.7% |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | 등급 없음 | US$2.1B | US$50.53 | — | — | — |
| TRVI | TREVI THERAPEUTICS, INC. | 등급 없음 | US$2.1B | US$14.82 | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | 등급 없음 | US$2.1B | US$21.76 | — | — | — |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | B+ | US$2B | US$34.23 | 11.30 | US$989.4M | 18.1% |
| MAZE | MAZE THERAPEUTICS, INC. | 등급 없음 | US$2B | US$36.72 | — | — | — |
| ZYME | ZYMEWORKS INC. | F+ | US$2B | US$29.03 | 55.83 | US$266M | 16.3% |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | US$2B | US$7.70 | — | US$213M | -30.8% |
| FTRE | Fortrea Holdings Inc. | C | US$2B | US$20.38 | — | US$2.7B | -2.6% |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | US$2B | US$32.83 | — | US$140.8M | -264.8% |
| ZBIO | Zenas BioPharma, Inc. | F- | US$1.9B | US$28.68 | — | US$10M | -5,418.1% |
| BRVE | Braveheart Bio, Inc. | 등급 없음 | US$1.9B | US$20.83 | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | 등급 없음 | US$1.9B | US$14.38 | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | 등급 없음 | US$1.8B | US$39.23 | — | — | — |
| STOK | Stoke Therapeutics, Inc. | F- | US$1.8B | US$27.72 | — | US$28.2M | -862.1% |
| SRPT | SAREPTA THERAPEUTICS, INC. | C | US$1.8B | US$16.68 | — | US$2B | -5.9% |
| NRIX | NURIX THERAPEUTICS, INC. | A+ | US$1.8B | US$16.33 | 7.10 | US$701.9M | 42.0% |
| MESO | MESOBLAST LIMITED | C- | US$1.8B | US$13.66 | — | US$65.4M | -144.3% |
| GENB | Generate Biomedicines, Inc. | 등급 없음 | US$1.7B | US$13.49 | — | — | — |
| ABSI | ABSCI CORP | F- | US$1.7B | US$10.08 | — | US$1.6M | -8,050.7% |
| QURE | uniQure N.V. | F- | US$1.7B | US$24.61 | — | US$20.2M | -1,154.8% |
| SLS | SELLAS Life Sciences Group, Inc. | 등급 없음 | US$1.7B | US$8.43 | — | — | — |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | US$1.7B | US$16.70 | — | US$730M | -71.8% |
| PGEN | PRECIGEN, INC. | C | US$1.7B | US$4.71 | 47.10 | US$156.9M | 15.6% |
| NVAX | NOVAVAX, INC. | F | US$1.6B | US$9.97 | — | US$411.6M | -18.6% |
| IMCR | Immunocore Holdings plc | F- | US$1.6B | US$31.64 | — | US$429.3M | -7.5% |
| NTLA | INTELLIA THERAPEUTICS, INC. | D- | US$1.6B | US$11.41 | — | US$52.9M | -805.7% |
| RAPP | Rapport Therapeutics, Inc. | 등급 없음 | US$1.6B | US$27.00 | — | — | — |
| NBTX | Nanobiotix S.A. | C- | US$1.6B | US$33.00 | — | US$36.4M | -73.5% |
| NUVB | Nuvation Bio Inc. | C- | US$1.5B | US$4.28 | — | US$201.7M | -67.4% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | US$1.5B | US$6.64 | — | US$50.4M | -648.6% |
| ANAB | ANAPTYSBIO, INC. | C+ | US$1.5B | US$48.73 | 8.49 | US$237.6M | 77.6% |
| TYRA | TYRA BIOSCIENCES, INC. | 등급 없음 | US$1.4B | US$20.93 | — | — | — |
| LBRX | LB Pharmaceuticals Inc | 등급 없음 | US$1.4B | US$44.65 | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | 등급 없음 | US$1.4B | US$23.24 | — | — | — |
| MLYS | MINERALYS THERAPEUTICS, INC. | 등급 없음 | US$1.4B | US$16.18 | — | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | D- | US$1.4B | US$15.19 | — | US$96.6M | -193.4% |
| AVLN | Avalyn Pharma Inc. | 등급 없음 | US$1.4B | US$31.57 | — | — | — |
| TSHA | Taysha Gene Therapies, Inc. | F- | US$1.4B | US$4.27 | — | US$5.5M | -2,844.6% |
| MNKD | MannKind Corporation | D | US$1.3B | US$4.18 | — | US$413.4M | -18.1% |
| INVA | INNOVIVA, INC. | C+ | US$1.3B | US$18.86 | 9.43 | US$438.3M | 44.1% |
| INBX | INHIBRX BIOSCIENCES, INC. | F- | US$1.3B | US$90.63 | — | US$1.3M | -10,629.3% |
| OMER | OMEROS CORP | 등급 없음 | US$1.3B | US$18.14 | 10.55 | — | — |
| NKTR | Nektar Therapeutics | F- | US$1.3B | US$38.43 | — | US$52.2M | -339.7% |
| URGN | UroGen Pharma Ltd. | C | US$1.3B | US$26.07 | — | US$250.3M | -26.3% |
| ANRO | Alto Neuroscience, Inc. | 등급 없음 | US$1.2B | US$31.15 | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | 등급 없음 | US$1.2B | US$14.05 | — | — | — |
| VOR | Vor Biopharma Inc. | 등급 없음 | US$1.2B | US$20.10 | 0.07 | — | — |
| GHRS | GH Research PLC | 등급 없음 | US$1.2B | US$19.22 | — | — | — |
| SGP | SpyGlass Pharma, Inc. | 등급 없음 | US$1.2B | US$34.90 | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 등급 없음 | US$1.1B | US$13.50 | — | — | — |
| VSTM | Verastem, Inc. | F- | US$1.1B | US$9.09 | — | US$100.3M | -178.4% |
| SPTX | Seaport Therapeutics, Inc. | 등급 없음 | US$1.1B | US$21.26 | — | — | — |
| SVRA | Savara Inc. | 등급 없음 | US$1.1B | US$4.99 | — | — | — |
| JBIO | Jade Biosciences, Inc. | 등급 없음 | US$1.1B | US$16.56 | — | — | — |
| ODTX | Odyssey Therapeutics, Inc. | 등급 없음 | US$1B | US$20.94 | — | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. | 등급 없음 | US$968.8M | US$11.49 | — | — | — |
| AKTS | Aktis Oncology, Inc. | 등급 없음 | US$950.8M | US$17.04 | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | US$936.9M | US$12.98 | — | US$92M | -217.8% |
| SLN | Silence Therapeutics plc | D- | US$934.1M | US$19.77 | — | US$615K | -8,361.1% |
| ORIC | ORIC PHARMACEUTICALS, INC. | 등급 없음 | US$930.8M | US$8.98 | — | — | — |
| MGTX | MeiraGTx Holdings plc | A | US$930.7M | US$9.69 | 13.65 | US$397.5M | 19.9% |
| PHAR | Pharming Group N.V. | A | US$929.4M | US$13.25 | 331.13 | US$376.1M | 0.8% |
| IMTX | Immatics N.V. | 등급 없음 | US$898.3M | US$6.70 | — | — | — |
| LTGO | Latigo Biotherapeutics, Inc. | 등급 없음 | US$897.7M | US$13.54 | — | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. | F- | US$880.1M | US$10.30 | — | US$70.3M | -186.2% |
| ANNX | ANNEXON, INC. | 등급 없음 | US$861.1M | US$4.19 | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | US$856.4M | US$9.59 | — | US$289.7M | -72.3% |
| ALMS | Alumis Inc. | F- | US$856.2M | US$6.62 | — | US$7.2M | -5,844.5% |
| SLDB | Solid Biosciences Inc. | 등급 없음 | US$849.4M | US$7.61 | — | — | — |
| RIGL | RIGEL PHARMACEUTICALS INC | B+ | US$837.7M | US$44.49 | 2.77 | US$288.2M | 106.6% |
| LXRX | Lexicon Pharmaceuticals, Inc. | D- | US$828.1M | US$1.86 | — | US$38.5M | -161.8% |
| SGMT | Sagimet Biosciences Inc. | 등급 없음 | US$814.3M | US$11.41 | — | — | — |
| AURA | AURA BIOSCIENCES, INC. | 등급 없음 | US$792M | US$7.61 | — | — | — |
| ARDX | ARDELYX, INC. | C- | US$785.5M | US$3.13 | — | US$468.2M | -11.8% |
| PRME | Prime Medicine, Inc. | D- | US$779M | US$4.30 | — | US$4.6M | -4,056.4% |
| IVA | Inventiva S.A. | F | US$776.8M | US$4.02 | — | US$5M | -7,899.6% |
| ATTO | Attovia Therapeutics, Inc. | 등급 없음 | US$766.8M | US$16.78 | — | — | — |
| JANX | Janux Therapeutics, Inc. | C- | US$755.6M | US$12.35 | — | US$23.3M | -428.7% |
| ACHV | Achieve Life Sciences, Inc. | 등급 없음 | US$747.1M | US$6.79 | — | — | — |
| OABI | OMNIAB, INC. | B | US$743.9M | US$5.10 | — | US$40.2M | -108.1% |
| CGEM | CULLINAN THERAPEUTICS, INC. | 등급 없음 | US$735.6M | US$11.33 | — | — | — |
| NVCT | NUVECTIS PHARMA, INC. | 등급 없음 | US$721.5M | US$20.98 | — | — | — |
| CLYM | Climb Bio, Inc. | 등급 없음 | US$719.5M | US$12.25 | — | — | — |
| KURA | Kura Oncology, Inc. | C- | US$710.2M | US$7.73 | — | US$79.3M | -369.3% |
| CADL | CANDEL THERAPEUTICS, INC. | 등급 없음 | US$705.1M | US$9.22 | — | — | — |
| ZVRA | Zevra Therapeutics, Inc. | B+ | US$704.8M | US$11.85 | 9.95 | US$147.8M | 52.8% |
| OLMA | OLEMA PHARMACEUTICALS, INC. | 등급 없음 | US$703.5M | US$8.03 | — | — | — |
| AVBP | ARRIVENT BIOPHARMA, INC. | 등급 없음 | US$699.3M | US$13.52 | — | — | — |
| APMD | Apnimed, Inc. | 등급 없음 | US$698.6M | US$16.78 | — | — | — |
| BCAX | BICARA THERAPEUTICS INC. | 등급 없음 | US$698.4M | US$10.52 | — | — | — |
| ACRS | Aclaris Therapeutics, Inc. | F- | US$689.2M | US$4.35 | — | US$6.4M | -1,244.1% |
| SANA | Sana Biotechnology, Inc. | 등급 없음 | US$689.2M | US$2.30 | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | US$689M | US$10.76 | — | US$0.00 | — |
| WVE | WAVE LIFE SCIENCES, INC. | F- | US$672.6M | US$3.41 | — | US$70.9M | -296.9% |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | F- | US$664.8M | US$10.26 | — | US$130.8M | -192.0% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | US$651.8M | US$11.21 | — | US$0.00 | — |
| GERN | GERON CORP | 등급 없음 | US$644.2M | US$1.00 | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | 등급 없음 | US$619.2M | US$8.66 | — | — | — |
| ABUS | ARBUTUS BIOPHARMA CORP | D+ | US$595.5M | US$3.89 | 3.44 | US$181.5M | 121.2% |
| CBIO | Crescent Biopharma, Inc. | D- | US$573.9M | US$14.76 | — | US$15M | -727.6% |
| RGNX | REGENXBIO Inc. | F- | US$560.1M | US$8.47 | — | US$153.9M | -113.9% |
| ENTX | ENTERA BIO LTD. | F | US$559.9M | US$3.22 | — | US$0.00 | — |
| DMAC | DIAMEDICA THERAPEUTICS INC. | 등급 없음 | US$521.2M | US$9.66 | — | — | — |
| NGNE | Neurogene Inc. | F | US$518.8M | US$25.06 | — | US$0.00 | — |
| STTK | Shattuck Labs, Inc. | F | US$512.3M | US$5.03 | — | US$0.00 | — |
| VALN | Valneva SE | F- | US$511.9M | US$5.90 | — | US$174.7M | -73.7% |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | US$510.5M | US$6.28 | — | US$274.9M | -30.2% |
| AVTX | AVALO THERAPEUTICS, INC. | F- | US$492.1M | US$8.51 | — | US$59K | -150,259.3% |
| GYRE | Gyre Therapeutics, Inc. | F- | US$491.8M | US$4.27 | — | US$108.1M | -33.9% |
| JSPR | Jasper Therapeutics, Inc. | 등급 없음 | US$491M | US$14.76 | — | — | — |
| MDXG | MIMEDX GROUP, INC. | F | US$483M | US$3.31 | — | US$303.7M | -6.3% |
| MNPR | Monopar Therapeutics Inc. | F | US$482.3M | US$71.86 | — | US$0.00 | — |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | US$474.6M | US$6.03 | — | US$31.2M | -182.5% |
| RLMD | RELMADA THERAPEUTICS, INC. | 등급 없음 | US$473.1M | US$4.44 | — | — | — |
| CTMX | CytomX Therapeutics, Inc. | F- | US$465.4M | US$2.14 | — | US$14M | -609.0% |
| ASMB | Assembly Biosciences, Inc. | B- | US$454.9M | US$22.34 | — | US$72.3M | -15.4% |
| ARVN | ARVINAS, INC. | C- | US$452.5M | US$6.91 | — | US$275.3M | -3.5% |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | D- | US$448.8M | US$8.74 | — | US$52.7M | -45.4% |
| YDES | YD Bio Limited | D | US$440.3M | US$6.22 | — | US$596.8K | -1,392.6% |
| TECX | TECTONIC THERAPEUTIC, INC. | 등급 없음 | US$438.9M | US$22.00 | — | — | — |
| KRSA | Korsana Biosciences, Inc. | F | US$427.5M | US$31.61 | — | US$1.9M | -3,098.7% |
| INDP | Indaptus Therapeutics, Inc. | 등급 없음 | US$426.4M | US$3.20 | — | — | — |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | 등급 없음 | US$422.9M | US$1.95 | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | US$418.2M | US$8.09 | 17.59 | US$231.8M | 10.3% |
| IRD | Opus Genetics, Inc. | F- | US$415.6M | US$4.30 | — | US$7.9M | -1,726.7% |
| LYEL | Lyell Immunopharma, Inc. | F- | US$414.5M | US$16.86 | — | US$15K | -1,701,066.7% |
| CRMD | CORMEDIX INC. | B+ | US$413.9M | US$5.31 | 2.59 | US$462.2M | 13.8% |
| OCS | Oculis Holding AG | 등급 없음 | US$397.6M | US$7.61 | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | F- | US$397.1M | US$3.95 | — | US$122.1M | -163.6% |
| KARD | Kardigan, Inc. | 등급 없음 | US$396.1M | US$15.72 | — | — | — |
| RZLT | Rezolute, Inc. | 등급 없음 | US$395.6M | US$4.09 | — | — | — |
| ALEC | Alector, Inc. | B+ | US$388.6M | US$2.61 | 7.46 | US$173.5M | 23.9% |
| CCCC | C4 Therapeutics, Inc. | D- | US$378.2M | US$2.88 | — | US$32.3M | -282.2% |
| ALT | ALTIMMUNE, INC. | D- | US$375.4M | US$1.93 | — | US$41K | -254,522.0% |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | US$373.5M | US$10.65 | — | US$59.2M | -5.5% |
| EDIT | EDITAS MEDICINE, INC. | B- | US$367.3M | US$2.38 | — | US$49.8M | -145.0% |
| PEPG | PEPGEN INC. | 등급 없음 | US$365M | US$5.27 | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | 등급 없음 | US$360.2M | US$6.65 | — | — | — |
| ANL | Adlai Nortye Ltd. | C | US$347.1M | US$10.86 | — | US$5M | -710.6% |
| IMUX | Immunic, Inc. | 등급 없음 | US$346.9M | US$8.16 | — | — | — |
| FTH | Faeth Therapeutics, Inc. | 등급 없음 | US$345M | US$13.35 | — | — | — |
| PROK | ProKidney Corp. | F- | US$340.2M | US$1.13 | — | US$775K | -13,326.7% |
| AVIR | Atea Pharmaceuticals, Inc. | 등급 없음 | US$338.1M | US$4.21 | — | — | — |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | US$337.7M | US$11.60 | — | US$65.3M | -96.9% |
| GALT | GALECTIN THERAPEUTICS INC. | 등급 없음 | US$332.3M | US$3.30 | — | — | — |
| BNTC | BENITEC BIOPHARMA INC. | D | US$329.6M | US$9.45 | — | US$0.00 | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | US$328.8M | US$3.22 | — | US$17M | -474.7% |
| AUTL | AUTOLUS THERAPEUTICS PLC | C- | US$327.6M | US$1.23 | — | US$137.4M | -186.4% |
| AGEN | AGENUS INC | D | US$327.1M | US$7.23 | 10.95 | US$133.9M | 23.0% |
| OCGN | OCUGEN, INC. | F | US$325.1M | US$0.96 | — | US$4.8M | -1,367.6% |
| TTRX | Turn Therapeutics Inc. | 등급 없음 | US$324.7M | US$10.62 | — | — | — |
| KYTX | Kyverna Therapeutics, Inc. | 등급 없음 | US$323.1M | US$5.11 | — | — | — |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | US$321.2M | US$8.04 | — | US$0.00 | — |
| SCTX | SCRIBE THERAPEUTICS INC. | 등급 없음 | US$319.3M | US$16.86 | — | — | — |
| IPSC | Century Therapeutics, Inc. | C- | US$317.8M | US$1.75 | — | US$109.2M | -90.5% |
| MPLT | MapLight Therapeutics, Inc. | 등급 없음 | US$317M | US$7.47 | — | — | — |
| CABA | CABALETTA BIO, INC. | 등급 없음 | US$315M | US$1.46 | — | — | — |
| EVMN | Evommune, Inc. | D- | US$313.9M | US$8.65 | — | US$10M | -1,130.7% |
| ALLO | Allogene Therapeutics, Inc. | C- | US$313.1M | US$0.90 | — | US$6.9M | -2,513.9% |
| VERU | VERU INC. | 등급 없음 | US$308.9M | US$2.11 | — | — | — |
| VOGX | Vogenx, Inc. | 등급 없음 | US$308.5M | US$20.77 | — | — | — |
| NAUT | NAUTILUS BIOTECHNOLOGY, INC. | 등급 없음 | US$306.3M | US$2.41 | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | US$302.5M | US$3.79 | — | US$22.4M | -269.7% |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | US$286.1M | US$3.75 | — | US$0.00 | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | 등급 없음 | US$284.6M | US$2.74 | — | — | — |
| LCTX | Lineage Cell Therapeutics, Inc. | F | US$284.5M | US$1.13 | — | US$10.8M | 16.2% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | US$280.7M | US$12.87 | — | US$0.00 | — |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | US$279.3M | US$3.10 | — | US$0.00 | — |
| INO | INOVIO PHARMACEUTICALS, INC. | C- | US$277.2M | US$1.48 | — | US$298.9K | -23,798.9% |
| QTTB | Q32 Bio Inc. | B | US$275.3M | US$9.20 | 2.65 | US$53.7M | 60.0% |
| RCKT | Rocket Pharmaceuticals, Inc. | D | US$271.1M | US$2.47 | — | US$0.00 | — |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | US$268.3M | US$9.31 | — | US$30.5M | -285.9% |
| PLX | PROTALIX BIOTHERAPEUTICS, INC. | A+ | US$264.3M | US$3.14 | 12.54 | US$84.7M | 24.3% |
| CAMP | CAMP4 Therapeutics Corporation | B- | US$261.7M | US$4.17 | — | US$5.3M | -2,276.3% |
| BCYC | Bicycle Therapeutics plc | C- | US$258.2M | US$3.69 | — | US$83.5M | -169.8% |
| CUVL | CLINUVEL PHARMACEUTICALS LIMITED | C+ | US$256.7M | US$5.09 | 11.07 | US$64.3M | 36.0% |
| DTIL | PRECISION BIOSCIENCES INC | D- | US$255.3M | US$9.14 | — | US$45M | -85.6% |
| LXEO | Lexeo Therapeutics, Inc. | 등급 없음 | US$252.3M | US$3.08 | — | — | — |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | US$250.9M | US$4.15 | — | US$229.3M | -119.9% |
| CTNM | Contineum Therapeutics, Inc. | 등급 없음 | US$249M | US$10.78 | — | — | — |
| IMRX | Immuneering Corporation | 등급 없음 | US$245.3M | US$3.79 | — | — | — |
| IRLA | Quince Therapeutics, Inc. | 등급 없음 | US$242.4M | US$39.53 | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | 등급 없음 | US$237.3M | US$16.17 | — | — | — |
| ACIU | AC IMMUNE SA | D- | US$229.9M | US$2.26 | — | US$4.5M | -1,903.0% |
| IKT | INHIBIKASE THERAPEUTICS, INC. | F | US$227.9M | US$1.63 | — | US$0.00 | — |
| ELDN | Eledon Pharmaceuticals, Inc. | 등급 없음 | US$217M | US$2.67 | — | — | — |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | US$213.8M | US$5.46 | — | US$4M | -4,058.0% |
| PALI | PALISADE BIO, INC. | F- | US$209.8M | US$1.17 | — | US$500K | -8,739.2% |
| RNAC | Cartesian Therapeutics, Inc. | F | US$208M | US$6.82 | — | US$1M | -12,435.2% |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS, INC. | 등급 없음 | US$205.8M | US$2.57 | — | — | — |
| HELP | CYBIN INC. | 등급 없음 | US$202.8M | US$9.39 | — | — | — |
| ARTV | Artiva Biotherapeutics, Inc. | F- | US$201.2M | US$4.07 | — | US$0.00 | — |
| ALPS | ALPS GROUP INC | 등급 없음 | US$199.7M | US$1.20 | — | — | — |
| OVID | Ovid Therapeutics Inc. | D- | US$197.7M | US$2.79 | — | US$1.5M | -2,971.3% |
| KRRO | Korro Bio, Inc. | D- | US$197.6M | US$14.40 | — | US$1.3M | -8,214.5% |
| CGEN | COMPUGEN LTD | B+ | US$196.7M | US$2.08 | 5.47 | US$75.9M | 47.9% |
| LIMN | LIMINATUS PHARMA, INC. | 등급 없음 | US$195.8M | US$2.92 | — | — | — |
| PYXS | Pyxis Oncology, Inc. | D- | US$195M | US$1.63 | — | US$13.9M | -625.7% |
| FATE | FATE THERAPEUTICS INC | F- | US$194.5M | US$1.60 | — | US$4.8M | -2,619.6% |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | US$191.2M | US$3.24 | — | US$0.00 | — |
| ACOG | Alpha Cognition Inc. | D- | US$189.8M | US$8.72 | — | US$15.3M | -153.6% |
| KROS | KEROS THERAPEUTICS, INC. | F- | US$187M | US$9.53 | — | US$40.8M | -151.4% |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | US$185.7M | US$1.89 | — | US$0.00 | — |
| MDWD | MEDIWOUND LTD. | F- | US$177.5M | US$13.83 | — | US$11.9M | -170.1% |
| GTBP | GT Biopharma, Inc. | 등급 없음 | US$176.8M | US$3.92 | 10.59 | — | — |
| IVVD | INVIVYD, INC. | D- | US$176.2M | US$0.60 | — | US$58.4M | -183.9% |
| SLGL | Sol-Gel Technologies Ltd. | D | US$176.1M | US$63.20 | — | US$1.8M | -341.3% |
| CURX | Curanex Pharmaceuticals Inc | 등급 없음 | US$175.6M | US$5.60 | — | — | — |
| UPB | UPSTREAM BIO, INC. | F- | US$174.8M | US$3.19 | — | US$2.9M | -5,712.3% |
| RNA | Atrium Therapeutics, Inc. | 등급 없음 | US$171.7M | US$7.96 | — | — | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | US$171.6M | US$4.13 | — | US$2M | 8,743.5% |
| STRO | SUTRO BIOPHARMA, INC. | D | US$169.9M | US$10.25 | — | US$45.1M | -344.2% |
| ANTX | AN2 Therapeutics, Inc. | 등급 없음 | US$169M | US$4.46 | — | — | — |
| SION | SIONNA THERAPEUTICS, INC. | 등급 없음 | US$167.1M | US$3.70 | — | — | — |
| HUMA | Humacyte, Inc. | C- | US$165M | US$0.59 | — | US$2.4M | -3,955.1% |
| TARA | Protara Therapeutics, Inc. | 등급 없음 | US$161.3M | US$2.62 | — | — | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 등급 없음 | US$160.6M | US$23.35 | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | US$160.1M | US$8.22 | — | US$0.00 | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 등급 없음 | US$154.2M | US$1.12 | — | — | — |
| CMPX | COMPASS THERAPEUTICS, INC. | F | US$149.5M | US$0.83 | — | US$0.00 | — |
| IPHA | Innate Pharma SA | F- | US$149M | US$1.59 | — | US$10.1M | -546.1% |
| MGNX | MACROGENICS, INC. | D- | US$148.6M | US$2.33 | — | US$154.9M | -33.2% |
| ARMP | ARMATA PHARMACEUTICALS, INC. | 등급 없음 | US$141.7M | US$3.81 | — | — | — |
| ZURA | Zura Bio Limited | 등급 없음 | US$137.7M | US$1.43 | — | — | — |
| CUE | Cue Biopharma, Inc. | D- | US$137.4M | US$18.92 | — | US$37.7M | -435.8% |
| OKUR | ONKURE THERAPEUTICS, INC. | 등급 없음 | US$135.5M | US$3.35 | — | — | — |
| CLLS | Cellectis S.A. | F- | US$135.4M | US$1.35 | — | US$56.6M | -115.4% |
| SPRB | Spruce Biosciences, Inc. | F | US$133.8M | US$46.54 | — | US$0.00 | — |
| PRQR | ProQR Therapeutics N.V. | C- | US$132.8M | US$1.26 | — | US$20.5M | -229.7% |
| ABEO | ABEONA THERAPEUTICS INC. | C- | US$130.9M | US$2.29 | — | US$39M | -160.3% |
| MENS | Jyong Biotech Ltd. | 등급 없음 | US$130.8M | US$1.72 | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | US$129.8M | US$4.50 | — | US$40K | -107,587.6% |
| MOLN | MOLECULAR PARTNERS AG | F | US$129.8M | US$3.22 | — | US$0.00 | — |
| LENZ | LENZ THERAPEUTICS, INC. | F- | US$128.8M | US$4.10 | — | US$12.4M | -1,135.0% |
| NERV | Minerva Neurosciences, Inc. | 등급 없음 | US$127.1M | US$2.55 | — | — | — |
| ADAG | Adagene Inc. | C- | US$126.2M | US$2.13 | — | US$7.7M | -229.6% |
| FHTX | Foghorn Therapeutics Inc. | B | US$125.3M | US$2.09 | 29.86 | US$112.1M | 8.4% |
| IBIO | iBio, Inc. | C- | US$124.4M | US$0.82 | — | US$1.1M | -3,244.2% |
| ENGN | enGene Therapeutics Inc. | 등급 없음 | US$121.3M | US$1.81 | — | — | — |
| PYPD | PolyPid Ltd | 등급 없음 | US$119.9M | US$6.59 | — | — | — |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | US$117.4M | US$0.48 | — | -US$1.2M | 5,253.5% |
| VYGR | Voyager Therapeutics, Inc. | F- | US$109.5M | US$1.76 | — | US$25.1M | -416.3% |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | US$108.3M | US$4.37 | — | US$194K | -3,985.6% |
| MSLE | Satellos Bioscience Inc. | 등급 없음 | US$107.1M | US$6.93 | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | 등급 없음 | US$106.7M | US$1.34 | — | — | — |
| CDXS | Codexis, Inc. | B- | US$106.7M | US$0.97 | — | US$88.3M | -21.8% |
| NKTX | Nkarta, Inc. | D | US$105.4M | US$1.47 | — | US$0.00 | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | 등급 없음 | US$105M | US$3.77 | — | — | — |
| VANI | Vivani Medical, Inc. | F | US$100.6M | US$1.12 | — | US$0.00 | — |
| NBP | NovaBridge Biosciences | 등급 없음 | US$99.4M | US$0.86 | — | — | — |
| AVXL | ANAVEX LIFE SCIENCES CORP. | 등급 없음 | US$97.3M | US$1.05 | — | — | — |
| ANIX | ANIXA BIOSCIENCES, INC. | 등급 없음 | US$96.6M | US$2.78 | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | US$96.2M | US$1.51 | — | US$0.00 | — |
| PMVP | PMV PHARMACEUTICALS, INC. | 등급 없음 | US$94.8M | US$1.26 | — | — | — |
| PLYX | Polaryx Therapeutics, Inc. | 등급 없음 | US$94.7M | US$1.90 | — | — | — |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | F | US$91.9M | US$1.60 | — | US$0.00 | — |
| ICCC | ImmuCell Corporation | B | US$91.7M | US$10.10 | 144.29 | US$30.7M | 2.6% |
| CHRS | Coherus Oncology, Inc. | C | US$90M | US$0.58 | — | US$53.6M | -253.4% |
| LONA | LeonaBio, Inc. | 등급 없음 | US$89.4M | US$3.77 | — | — | — |
| EQ | EQUILLIUM, INC. | D- | US$89.4M | US$1.41 | — | US$41.1M | -43.8% |
| SEER | SEER, INC. | F- | US$89.3M | US$1.60 | — | US$14.1M | -450.9% |
| NMRA | NEUMORA THERAPEUTICS, INC. | 등급 없음 | US$88.3M | US$0.47 | — | — | — |
| CBUS | Cibus, Inc. | C- | US$87.9M | US$1.15 | — | US$4.5M | -2,131.4% |
| NRXS | NEURAXIS, INC. | D- | US$86.9M | US$6.12 | — | US$6.5M | -185.2% |
| GNLX | GENELUX CORPORATION | F- | US$86.4M | US$1.91 | — | US$8K | -444,950.0% |
| RLYB | RALLYBIO CORPORATION | A | US$85.1M | US$15.81 | — | US$434K | 6,177.4% |
| IFRX | InflaRx N.V. | F- | US$84.9M | US$1.18 | — | US$32.8K | -155,582.1% |
| TNYA | TENAYA THERAPEUTICS, INC. | 등급 없음 | US$84.5M | US$0.37 | — | — | — |
| MIST | Milestone Pharmaceuticals Inc. | 등급 없음 | US$84.4M | US$0.68 | — | — | — |
| ATRA | Atara Biotherapeutics, Inc. | F | US$84.2M | US$8.26 | — | US$4M | -368.6% |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 등급 없음 | US$82.6M | US$4.01 | — | — | — |
| JAGX | Jaguar Health, Inc. | C | US$82.4M | US$0.48 | — | US$27.8M | -132.2% |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | US$78.9M | US$0.57 | — | US$6.6M | -493.0% |
| TENX | TENAX THERAPEUTICS, INC. | F | US$77.2M | US$1.70 | — | US$0.00 | — |
| TLSA | Tiziana Life Sciences Ltd | 등급 없음 | US$76M | US$0.63 | — | — | — |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | US$74.6M | US$3.84 | — | US$43M | -420.4% |
| COYA | Coya Therapeutics, Inc. | F- | US$74.6M | US$3.18 | — | US$4.7M | -643.5% |
| OKYO | OKYO Pharma Limited | 등급 없음 | US$73.7M | US$1.41 | — | — | — |
| NTRB | NUTRIBAND INC. | F- | US$72.3M | US$5.95 | — | US$1.6M | -430.4% |
| GOSS | GOSSAMER BIO, INC. | B | US$71.4M | US$11.68 | — | US$78.4M | -159.5% |
| MNOV | MEDICINOVA, INC. | C- | US$68.9M | US$1.40 | — | US$920.5K | -1,168.2% |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | D- | US$68M | US$0.36 | — | US$148.2M | -14.5% |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | US$67.9M | US$4.88 | — | US$60.7M | -1.8% |
| ACRV | Acrivon Therapeutics, Inc. | 등급 없음 | US$67.7M | US$1.58 | — | — | — |
| CING | Cingulate Inc. | 등급 없음 | US$67.6M | US$4.65 | — | — | — |
| CNXU | CONEXEU SCIENCES INC. | 등급 없음 | US$67.4M | US$2.39 | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | D- | US$66.8M | US$3.89 | — | US$22.9M | -189.2% |
| CGTX | Cognition Therapeutics, Inc. | 등급 없음 | US$64.3M | US$0.68 | — | — | — |
| MAIA | MAIA BIOTECHNOLOGY, INC. | 등급 없음 | US$64.2M | US$1.04 | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | US$63.9M | US$2.01 | — | US$68.5M | 163.3% |
| XLO | Xilio Therapeutics, Inc. | D- | US$62.5M | US$8.85 | — | US$55M | -20.9% |
| CLNN | Clene Inc. | C | US$60.4M | US$4.20 | — | US$238K | -11,271.4% |
| SPRO | Spero Therapeutics, Inc. | C | US$60M | US$1.03 | 7.36 | US$47M | 15.7% |
| XBIT | XBiotech Inc. | 등급 없음 | US$59.8M | US$1.96 | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | US$59.6M | US$0.77 | — | US$559K | -6,735.2% |
| RNXT | RENOVORX, INC. | D- | US$59.3M | US$1.23 | — | US$2.8M | -469.0% |
| BOLD | BOUNDLESS BIO, INC. | 등급 없음 | US$57.6M | US$2.44 | — | — | — |
| PDSB | PDS Biotechnology Corporation | 등급 없음 | US$56.5M | US$1.01 | — | — | — |
| BCAB | BIOATLA, INC. | 등급 없음 | US$56.1M | US$1.74 | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | 등급 없음 | US$56M | US$1.72 | — | — | — |
| INKT | MiNK Therapeutics, Inc. | 등급 없음 | US$55.1M | US$10.79 | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | US$53.3M | US$13.20 | 1.57 | US$0.00 | — |
| RNTX | Rein Therapeutics, Inc. | F | US$52.8M | US$0.61 | — | US$0.00 | — |
| ONCY | ONCOLYTICS BIOTECH INC. | 등급 없음 | US$52.6M | US$0.41 | — | — | — |
| AZR | AZORA THERAPEUTICS, INC. | 등급 없음 | US$52.4M | US$3.67 | — | — | — |
| ATNM | Actinium Pharmaceuticals, Inc. | D+ | US$50.9M | US$1.62 | 4.50 | US$90K | 12,564.4% |
| CLGN | CollPlant Biotechnologies Ltd | D- | US$50.7M | US$3.96 | — | US$318K | -4,130.2% |
| MREO | MEREO BIOPHARMA GROUP PLC | C | US$48.8M | US$0.31 | — | US$500K | -5,387.6% |
| GANX | GAIN THERAPEUTICS, INC | 등급 없음 | US$48.8M | US$1.10 | — | — | — |
| PLRX | PLIANT THERAPEUTICS, INC. | D | US$48.3M | US$0.78 | — | US$0.00 | — |
| HYFT | MindWalk Holdings Corp. | C- | US$47.9M | US$1.03 | — | US$20.1M | -43.6% |
| HOWL | WEREWOLF THERAPEUTICS, INC. | 등급 없음 | US$47.9M | US$0.98 | — | — | — |
| IMA | ImageneBio, Inc. | C- | US$47.8M | US$3.84 | — | US$800K | -5,415.6% |
| DWTX | Dogwood Therapeutics, Inc. | 등급 없음 | US$46.3M | US$1.21 | — | — | — |
| ELTX | Elicio Therapeutics, Inc. | 등급 없음 | US$45.7M | US$1.62 | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | 등급 없음 | US$45.3M | US$1.91 | — | — | — |
| BMEA | Biomea Fusion, Inc. | 등급 없음 | US$44.4M | US$0.61 | — | — | — |
| BLSM | BlossomHill Therapeutics, Inc. | 등급 없음 | US$43.7M | US$16.10 | — | — | — |
| TELO | Telomir Pharmaceuticals, Inc. | 등급 없음 | US$43.7M | US$0.59 | — | — | — |
| CNTB | Connect Biopharma Holdings Limited | C- | US$43M | US$0.68 | — | US$3M | -2,336.3% |
| TIL | Instil Bio, Inc. | C- | US$42.9M | US$6.32 | — | US$9M | -337.7% |
| HYPD | HYPERION DEFI, INC. | D+ | US$42.3M | US$2.73 | — | US$1.4M | 474.9% |
| CRBU | Caribou Biosciences, Inc. | F- | US$42.1M | US$0.39 | — | US$9.4M | -1,085.0% |
| SER | Serina Therapeutics, Inc. | D | US$40.9M | US$1.54 | — | US$260K | -9,421.5% |
| OSTX | OS THERAPIES INCORPORATED | 등급 없음 | US$40.9M | US$0.89 | — | — | — |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | US$40M | US$1.57 | — | US$357.9K | -3,089.6% |
| GRCE | Grace Therapeutics, Inc. | 등급 없음 | US$39.5M | US$1.88 | — | — | — |
| GRDX | GridAI Technologies Corp. | F- | US$39.4M | US$5.53 | — | US$36.3K | -56,864.0% |
| ALDX | ALDEYRA THERAPEUTICS, INC. | 등급 없음 | US$39.2M | US$0.65 | — | — | — |
| EXOZ | EXOZYMES INC. | 등급 없음 | US$38.6M | US$4.16 | — | — | — |
| IBO | Impact BioMedical, INC. | A | US$37.2M | US$4.30 | — | US$38K | 4,247.4% |
| TVGN | Tevogen Inc. | 등급 없음 | US$37M | US$5.68 | — | — | — |
| ANVS | Annovis Bio, Inc. | F | US$36M | US$0.84 | — | US$0.00 | — |
| NNVC | NANOVIRICIDES, INC. | F | US$35.7M | US$1.40 | — | US$0.00 | — |
| PTHS | Pelthos Therapeutics Inc. | C- | US$35.7M | US$9.33 | — | US$58.4M | -133.6% |
| AARD | AARDVARK THERAPEUTICS, INC. | F | US$34.8M | US$1.59 | — | US$0.00 | — |
| INMB | INMUNE BIO INC. | D- | US$34.1M | US$1.10 | — | US$50K | -33,332.0% |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | 등급 없음 | US$33.9M | US$0.78 | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | 등급 없음 | US$33.9M | US$3.78 | — | — | — |
| EYPT | EyePoint, Inc. | F- | US$31.5M | US$0.37 | — | US$2.6M | -13,281.2% |
| BCTX | BRIACELL THERAPEUTICS CORP. | 등급 없음 | US$31.1M | US$3.57 | — | — | — |
| SKYE | Skye Bioscience, Inc. | 등급 없음 | US$30.3M | US$0.86 | — | — | — |
| LITS | Lite Strategy, Inc. | D | US$29.2M | US$0.98 | — | US$0.00 | — |
| NXTC | NextCure, Inc. | 등급 없음 | US$28.8M | US$6.29 | — | — | — |
| MGX | Metagenomi Therapeutics, Inc. | F- | US$28.3M | US$0.75 | — | US$22.3M | -421.8% |
| ACET | Adicet Bio, Inc. | 등급 없음 | US$27.9M | US$2.98 | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | 등급 없음 | US$27.8M | US$4.07 | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | F- | US$27.5M | US$2.20 | — | US$5.8M | -1,137.2% |
| ABVC | ABVC BioPharma, Inc. | D- | US$26.9M | US$1.00 | — | US$296K | -1,322.6% |
| CRVO | CervoMed Inc. | F- | US$26.8M | US$1.77 | — | US$8.7K | -326,822.5% |
| BYSI | BeyondSpring Inc. | D | US$26.4M | US$0.64 | — | US$0.00 | — |
| IMMP | Immutep Limited | D- | US$26.4M | US$3.58 | — | US$7.3M | -594.6% |
| BSEM | BioStem Technologies, Inc. | F- | US$26.2M | US$1.47 | — | US$34.6M | -81.8% |
| ATHE | ALTERITY THERAPEUTICS LTD | 등급 없음 | US$24.6M | US$2.31 | — | — | — |
| ENLV | Enlivex Ltd. | 등급 없음 | US$24.4M | US$1.26 | 0.01 | — | — |
| FLNA | Filana Therapeutics, Inc. | 등급 없음 | US$24.2M | US$0.48 | — | — | — |
| EVAX | Evaxion A/S | B- | US$24.2M | US$2.90 | — | US$7.5M | -102.4% |
| CELU | Celularity Inc. | D | US$24.1M | US$0.74 | — | US$18.7M | -245.7% |
| APRE | Aprea Therapeutics, Inc. | 등급 없음 | US$23.9M | US$0.44 | — | — | — |
| CVM | CEL-SCI CORPORATION | 등급 없음 | US$23.1M | US$1.32 | — | — | — |
| IGC | IGC PHARMA, INC. | C- | US$22.8M | US$0.20 | — | US$1.3M | -560.3% |
| EDSA | EDESA BIOTECH, INC. | 등급 없음 | US$22.1M | US$2.29 | — | — | — |
| NRXP | NRX Pharmaceuticals, Inc. | B | US$21.5M | US$2.43 | — | US$3.4M | -691.8% |
| ICU | SeaStar Medical Holding Corporation | D- | US$21.4M | US$1.89 | — | US$2.2M | -678.2% |
| ATOS | ATOSSA THERAPEUTICS, INC. | 등급 없음 | US$20.3M | US$2.03 | — | — | — |
| APLM | Apollomics Inc. | B | US$20.1M | US$18.25 | — | US$8.5M | -128.7% |
| COCP | COCRYSTAL PHARMA, INC. | 등급 없음 | US$19.9M | US$1.04 | — | — | — |
| CNTX | CONTEXT THERAPEUTICS INC. | 등급 없음 | US$19.6M | US$0.21 | — | — | — |
| KTTA | PASITHEA THERAPEUTICS CORP. | 등급 없음 | US$18.4M | US$0.55 | — | — | — |
| LPCN | LIPOCINE INC. | D- | US$17.7M | US$1.60 | — | US$3.7M | -249.2% |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | US$17.5M | US$1.31 | — | US$7.6M | -344.2% |
| ATYR | ATYR PHARMA, INC. | F- | US$17.4M | US$6.81 | — | US$190K | -28,065.3% |
| ABOS | Acumen Pharmaceuticals, Inc. | 등급 없음 | US$16.9M | US$0.23 | — | — | — |
| GOVX | GEOVAX LABS, INC. | F | US$15.9M | US$2.16 | — | US$0.00 | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | US$15.8M | US$0.95 | — | US$3.9M | -220.5% |
| YARW | YARROW BIOSCIENCE, INC. | D- | US$15.5M | US$18.10 | — | US$482K | -3,881.5% |
| MCRB | Seres Therapeutics, Inc. | D- | US$15.4M | US$1.51 | — | US$2.1M | -2,209.6% |
| ALLR | Allarity Therapeutics, Inc. | B- | US$15.2M | US$0.95 | — | US$345K | -3,575.1% |
| KYNB | KYNTRA BIO, INC. | F | US$15.1M | US$3.74 | — | US$4.6M | 3,967.8% |
| ONCO | Onconetix, Inc. | F- | US$14.8M | US$3.76 | — | US$645.8K | -1,578.8% |
| PLUR | Pluri Inc. | F | US$14.8M | US$1.20 | — | US$1M | -2,344.6% |
| BCDA | BioCardia, Inc. | F | US$13.9M | US$0.92 | — | US$0.00 | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | US$13.8M | US$0.38 | — | US$3.8M | -200.5% |
| BIVI | BIOVIE INC. | 등급 없음 | US$13.5M | US$1.26 | — | — | — |
| CTXR | Citius Pharmaceuticals, Inc. | 등급 없음 | US$13.2M | US$0.48 | — | — | — |
| NCEL | NewcelX Ltd. | 등급 없음 | US$13.1M | US$2.74 | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | US$12.6M | US$0.19 | — | US$7.1M | -1,618.4% |
| ELAB | PMGC HOLDINGS INC. | D- | US$12.5M | US$1.54 | — | US$2.6M | -523.0% |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | US$12.3M | US$6.90 | — | US$13.2M | -63.6% |
| NIKI | Niki BioSolutions, Inc. | 등급 없음 | US$12.3M | US$1.67 | — | — | — |
| PASG | Passage BIO, Inc. | 등급 없음 | US$12.2M | US$3.81 | — | — | — |
| KAPA | KAIROS PHARMA, LTD. | 등급 없음 | US$12.1M | US$0.51 | — | — | — |
| KZIA | Kazia Therapeutics Limited. | F | US$12.1M | US$7.46 | 6.57 | US$29.5K | -54,287.3% |
| BOLT | Bolt Biotherapeutics, Inc. | F- | US$12M | US$6.25 | — | US$4.7M | -553.6% |
| CLRB | Cellectar Biosciences, Inc. | 등급 없음 | US$11.8M | US$1.18 | — | — | — |
| AZTR | Azitra, Inc. | F- | US$11.7M | US$0.61 | — | US$0.00 | — |
| GUTS | Fractyl Health, Inc. | F- | US$11.6M | US$0.87 | — | US$0.00 | — |
| INTS | INTENSITY THERAPEUTICS, INC. | 등급 없음 | US$11.2M | US$3.38 | — | — | — |
| HIND | VYOME HOLDINGS, INC. | F- | US$10.8M | US$1.54 | — | US$129.7K | -8,716.8% |
| LSTA | Lisata Therapeutics, Inc. | D- | US$10.7M | US$1.19 | — | US$100K | -14,621.0% |
| DARE | Dare Bioscience, Inc. | C- | US$10.7M | US$0.70 | — | US$1.4M | -804.4% |
| ARTL | ARTELO BIOSCIENCES, INC. | 등급 없음 | US$10M | US$2.18 | — | — | — |
| GDTC | CytoMed Therapeutics Limited | D- | US$10M | US$0.85 | — | US$253.7K | -1,227.1% |
| CMMB | SNOWDRIFT PARENT CORPORATION | 등급 없음 | US$9.9M | US$1.38 | — | — | — |
| INAB | IN8BIO, INC. | 등급 없음 | US$9.8M | US$0.91 | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | US$9.7M | US$0.82 | — | US$3.6M | -1,055.3% |
| MTVA | METAVIA INC. | 등급 없음 | US$9.5M | US$1.44 | — | — | — |
| CALC | CalciMedica, Inc. | 등급 없음 | US$8.8M | US$1.27 | — | — | — |
| AEON | AEON Biopharma, Inc. | 등급 없음 | US$8.6M | US$0.17 | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | US$8.3M | US$0.19 | — | US$2.5M | -2,702.6% |
| SNGX | SOLIGENIX, INC. | 등급 없음 | US$7.5M | US$0.32 | — | — | — |
| TOVX | Theriva Biologics, Inc. | 등급 없음 | US$7.4M | US$0.16 | — | — | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | 등급 없음 | US$7.3M | US$0.31 | — | — | — |
| IMRN | IMMURON LIMITED | D- | US$7.2M | US$0.89 | — | US$5.1M | -71.6% |
| ENVB | ENVERIC BIOSCIENCES, INC. | 등급 없음 | US$6.8M | US$1.52 | — | — | — |
| ENSC | Ensysce Biosciences, Inc. | D- | US$6.8M | US$0.35 | — | US$4.5M | -280.5% |
| XCUR | EXICURE, INC. | F | US$6.8M | US$1.04 | — | US$0.00 | — |
| ALZN | ALZAMEND NEURO, INC. | 등급 없음 | US$6.4M | US$1.34 | — | — | — |
| BLRX | BioLineRx Ltd | C- | US$6.4M | US$1.48 | — | US$1.4M | -145.5% |
| FBLG | FibroBiologics, Inc. | 등급 없음 | US$6.2M | US$0.94 | — | — | — |
| LTRN | LANTERN PHARMA INC. | 등급 없음 | US$6.2M | US$0.49 | — | — | — |
| CNSY | CERENOME, INC. | F- | US$6.1M | US$0.80 | — | US$4.2M | -620.7% |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | US$5.9M | US$1.33 | — | US$0.00 | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | B- | US$5.8M | US$1.96 | — | US$15.2K | -42,721.9% |
| TPST | Tempest Therapeutics, Inc. | 등급 없음 | US$5.8M | US$0.39 | — | — | — |
| CMND | Clearmind Medicine Inc. | 등급 없음 | US$5.8M | US$4.95 | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | 등급 없음 | US$5.6M | US$0.88 | — | — | — |
| ACXP | Acurx Pharmaceuticals, Inc. | 등급 없음 | US$5.5M | US$1.04 | — | — | — |
| PCSA | Processa Pharmaceuticals, Inc. | 등급 없음 | US$5.2M | US$1.87 | — | — | — |
| PULM | Pulmatrix, Inc. | C- | US$5.1M | US$1.39 | — | US$7.8M | -51.4% |
| CVKD | Cadrenal Therapeutics, Inc. | 등급 없음 | US$4.9M | US$1.37 | — | — | — |
| SNTI | Senti Biosciences Holdings, Inc. | F- | US$4.9M | US$0.16 | — | US$55K | -90,116.4% |
| CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | D- | US$4.7M | US$0.62 | — | US$3K | -249,160.1% |
| IMNN | Imunon, Inc. | 등급 없음 | US$4.7M | US$0.72 | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | US$4.6M | US$0.43 | — | US$0.00 | — |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | US$4.5M | US$1.91 | — | US$451K | -1,545.2% |
| AIM | AIM ImmunoTech Inc. | D | US$4.5M | US$0.15 | — | US$95K | -15,021.1% |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | US$4.2M | US$1.80 | — | US$3.3M | -75.9% |
| OSRH | OSR HEALTH, INC. | D- | US$4.1M | US$0.12 | — | US$1.8M | -824.4% |
| TCRT | Alaunos Therapeutics, Inc. | D- | US$4.1M | US$1.61 | — | US$3K | -133,666.7% |
| PHIO | Phio Pharmaceuticals Corp | 등급 없음 | US$4M | US$0.84 | — | — | — |
| GRI | GRI BIO, INC. | 등급 없음 | US$4M | US$1.84 | — | — | — |
| TRAW | Traws Pharma, Inc. | D- | US$3.8M | US$0.24 | — | US$2.8M | -773.0% |
| AGMB | AgomAb Therapeutics NV | 등급 없음 | US$3.8M | US$6.93 | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | 등급 없음 | US$3.5M | US$0.71 | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | US$3.5M | US$2.81 | — | US$36.4K | -22,448.4% |
| MBIO | MUSTANG BIO, INC. | 등급 없음 | US$3.4M | US$0.45 | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | 등급 없음 | US$3.3M | US$1.95 | — | — | — |
| EVGN | EVOGENE LTD. | F | US$3.2M | US$0.37 | — | US$1.3M | -551.3% |
| SILO | SILO PHARMA, INC. | F- | US$2.9M | US$1.83 | — | US$54.1K | -8,269.5% |
| REVB | REVELATION BIOSCIENCES, INC. | 등급 없음 | US$2.9M | US$4.23 | — | — | — |
| VRAX | Virax Biolabs Group Ltd | C- | US$2.2M | US$0.60 | — | US$6.3K | -95,739.2% |
| SLXN | Silexion Therapeutics Corp | 등급 없음 | US$2.2M | US$3.23 | — | — | — |
| QNTM | Quantum BioPharma Ltd. | 등급 없음 | US$2.2M | US$1.95 | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | 등급 없음 | US$2M | US$1.74 | — | — | — |
| GNPX | Genprex, Inc. | D | US$1.8M | US$2.25 | — | US$0.00 | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | US$1.8M | US$0.52 | — | US$1.1M | -729.9% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | US$1.8M | US$0.51 | — | US$3.1M | -270.9% |
| CLDI | Calidi Biotherapeutics, Inc. | 등급 없음 | US$1.7M | US$0.68 | — | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | US$1.7M | US$2.21 | — | US$21.8K | -42,206.9% |
| PBM | PSYENCE BIOMEDICAL LTD | 등급 없음 | US$1.7M | US$3.03 | — | — | — |
| HCWB | HCW Biologics Inc. | B- | US$1.7M | US$0.91 | — | US$6.7M | -83.8% |
| OGEN | ORAGENICS, INC. | 등급 없음 | US$1.6M | US$0.36 | — | — | — |
| APVO | Aptevo Therapeutics Inc. | 등급 없음 | US$1.4M | US$0.76 | — | — | — |
| BDRX | Biodexa Pharmaceuticals PLC | 등급 없음 | US$1.3M | US$2.44 | — | — | — |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | 등급 없음 | US$1.3M | US$1.38 | — | — | — |
| CANF | Can-Fite BioPharma Ltd. | F- | US$1.3M | US$1.57 | — | US$405K | -2,426.7% |
| CRIS | CURIS, INC. | F- | US$1.2M | US$0.60 | — | US$4.3M | -490.3% |
| BBLG | Bone Biologics Corporation | 등급 없음 | US$1.2M | US$0.36 | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | 등급 없음 | US$903.6K | US$0.38 | — | — | — |
| VIVS | VivoSim Labs, Inc. | F | US$797.4K | US$0.15 | — | US$112K | -11,016.1% |
| HLSQ | BiomX Inc. | 등급 없음 | US$739.4K | US$0.07 | — | — | — |
| DCOY | Decoy Therapeutics Inc. | 등급 없음 | US$710.9K | US$1.09 | — | — | — |
| QNRX | Quoin Pharmaceuticals, Ltd. | 등급 없음 | US$667.8K | US$3.80 | — | — | — |
| EDVA | Endovia Health Sciences, Inc. | D | US$548.9K | US$0.18 | — | US$32.1K | -53,856.5% |
| PLRZ | Polyrizon Ltd. | 등급 없음 | US$503.9K | US$11.11 | 2.27 | — | — |
| LGVN | LONGEVERON INC. | F- | US$449.8K | US$3.25 | — | US$1.2M | -1,921.7% |
| VBIO | Valion Bio, Inc. | F- | US$435.4K | US$0.49 | — | US$482K | -3,890.0% |
| CDT | CDT EQUITY INC. | 등급 없음 | US$402.1K | US$0.51 | — | — | — |
| SRZN | Surrozen, Inc./DE | D | US$374.6K | US$31.82 | — | US$10.5M | -3,706.4% |
| SPRC | SCISPARC LTD. | F- | US$144.5K | US$0.40 | — | US$679K | -1,793.7% |
| NEUP | Neuphoria Therapeutics Inc. | F- | US$81.2K | US$2.70 | — | US$1.2M | -1,145.7% |
| KALA | KALA BIO, INC. | F | US$12.7K | US$0.17 | — | US$0.00 | — |
| KPTI | Karyopharm Therapeutics Inc. | C | US$503.52 | US$0.02 | — | US$146.6M | -153.3% |
| PPBT | PURPLE BIOTECH LTD. | 등급 없음 | US$331.24 | US$1.38 | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | 등급 없음 | — | US$13.25 | — | — | — |
| APGE | Apogee Therapeutics, Inc. | 등급 없음 | — | US$135.07 | — | — | — |
| ATAI | AtaiBeckley Inc. | 등급 없음 | — | US$7.35 | — | US$4.1M | -16,142.0% |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | US$0.74 | — | US$0.00 | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | US$84.95 | — | US$42.2M | -1,189.9% |
| ETRA | Electra Therapeutics, Inc. | 등급 없음 | — | US$9.42 | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | 등급 없음 | — | US$76.99 | — | — | — |
| LNAI | LUNAI BIOWORKS INC. | B | — | US$0.16 | — | US$52K | -6,852.0% |
| MLEC | MOOLEC SCIENCE SA | B | — | US$0.85 | — | US$333.6M | -52.9% |
| SLBT | SL Science Holding Ltd | 등급 없음 | — | US$0.68 | — | — | — |
| TBPH | Theravance Biopharma, Inc. | C | — | US$17.03 | — | US$104.3M | 51.6% |
| VCRE | Vicore Pharma Holding AB | 등급 없음 | — | US$11.03 | — | — | — |
| VRXA | Veraxa Biotech Holding AG | 등급 없음 | — | US$1.28 | — | — | — |
| VTVT | vTv Therapeutics Inc. | C- | — | US$21.55 | — | US$36.8M | -20.8% |
펀더멘털은 SEC 공시에서, 주가는 가장 최근 시세 갱신에서 가져왔습니다. 어떤 열로도 정렬할 수 있으며, 수치가 없는 기업은 어느 방향으로 정렬하든 맨 뒤에 놓입니다.
시가총액이 큰 순으로 정렬했습니다. 아무 열이나 눌러 다시 정렬할 수 있습니다. 수치가 없는 기업은 어느 방향으로 정렬하든 맨 뒤에 놓이는데, PER이 없다는 것은 싸다는 뜻이 아니라 적자라는 뜻이기 때문입니다. 여기 어떤 것도 투자 권유가 아닙니다.